Latest Amgen News & Updates

See the latest news and media coverage for Amgen. We track all announcements, press releases, and industry mentions in real time, all in one place.

Amgen

Multinational biopharmaceutical company

amgen.com

Headquarters: Thousand Oaks, United States
Founded year: 1980
Company type: Public company
Number of employees: 35,000+
Industry: Biotechnology & Medical Research

Last updated Today

Latest news about Amgen

In short: Amgen raised its 2026 guidance following strong sales and positive data for Repatha and Imdelltra, despite facing regulatory woes for Tavneos.

Company announcements

September 14 Amgen

Amgen secures FDA approval for reduced monitoring time for IMDELLTRA

The updated prescribing information lowers initial infusion observation from 22 hours to 6-8 hours, facilitating broader access in community oncology settings.

September 8 Amgen

Amgen reports improved survival for its lung cancer drug

The phase 3 DeLLphi-305 trial met primary and secondary endpoints for overall survival, progression-free survival, and objective response rate compared to standard care.

August 31 Amgen

Amgen Announces Repatha Lowers Death Risk For High-Risk Cardiac Patients

Clinical trial results show a 20% reduction in all-cause mortality among over 12,000 participants receiving treatment alongside statins.

August 20 Amgen

Amgen places 39th on the Wall Street Journal 2026 list

The ranking evaluates AI readiness, innovation, talent, finance, resilience, and agility, highlighting Amgen's top-tier scores among all evaluated firms.

Media coverage

Yesterday Reuters

Bristol Myers sues Amgen over proposed Opdivo biosimilar

Bristol Myers Squibb and Ono Pharmaceutical have sued Amgen in Delaware federal court, seeking to block Amgen's proposed U.S. biosimilar of their blockbuster cancer immunotherapy...

September 11 Yahoo Finance

Amgen Highlights MariTide, IMDELLTRA Pipeline Progress and Growth Priorities

Amgen (NASDAQ:AMGN) outlined its growth priorities, late-stage pipeline progress and capital-allocation framework during a Morgan Stanley conference, as newly appointed Chief Financial Officer Thomas Dittrich...

September 9 The Cardinal

Beyond CV Events, Evolocumab Lowers All-Cause Mortality: VESALIUS-CV

It’s unlikely a lipid-lowering agent can directly reduce infection or malignancy, but some argue it could stop a domino effect.

September 8 Citeline

Amgen Stands To Broaden Imdelltra Market With First-Line Maintenance ES-SCLC Data

Topline Phase III results for DLL3-inhibiting bispecific Imdelltra plus AstraZeneca’s Imfinzi showed improved survival as a ...

Never miss news about Amgen

Track Amgen and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.